World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology-Reference-Cited by-同舟云学术

World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology

Published:2007-09-06 Issue:1 Volume:6 Page:
ISSN:1475-2875
Container-title:Malaria Journal
language:en
Short-container-title:Malar J

Author:

Barnes Karen I,Lindegardh Niklas,Ogundahunsi Olumide,Olliaro Piero,Plowe Christopher V,Randrianarivelojosia Milijaona,Gbotosho Grace O,Watkins William M,Sibley Carol H,White Nicholas J

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Parasitology

Link

http://link.springer.com/article/10.1186/1475-2875-6-122/fulltext.html

Reference30 articles.

1. Sibley CH, Barnes KI, Plowe CV: The rationale and plan for creating a World Antimalarial Resistance Network. Malar J. 2007, 6 (1): 118-10.1186/1475-2875-6-118.

2. McGready R, Stepniewska K, Lindegardh N, Ashley EA, La Y, Singhasivanon P, White NJ, Nosten F: The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria. Eur J Clin Pharmacol. 2006, 62: 1021-1031. 10.1007/s00228-006-0199-7.

3. Fakeye TO, Fehintola FA, Ademowo OG, Walker O: Therapeutic monitoring of chloroquine in pregnant women with malaria. West Afr J Med. 2002, 21: 286-287.

4. Na Bangchang K, Davis TM, Looareesuwan S, White NJ, Bunnag D, Karbwang J: Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria. Trans R Soc Trop Med Hyg. 1994, 88: 321-323. 10.1016/0035-9203(94)90101-5.

5. McGready R, Stepniewska K, Edstein MD, Cho T, Gilveray G, Looareesuwan S, White NJ, Nosten F: The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. Eur J Clin Pharmacol. 2003, 59: 545-552. 10.1007/s00228-003-0652-9.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutritional Frameworks in Malaria;Nutrition and Infectious Diseases;2020-12-11

2. The Role of Clinical Pharmacology in Chemotherapy of Multidrug‐Resistant Plasmodium falciparum;The Journal of Clinical Pharmacology;2020-02-27

3. Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania;Malaria Journal;2020-02-11

4. CYP2B6 *6 Genotype Specific Differences in Artemether‐Lumefantrine Disposition in Healthy Volunteers;The Journal of Clinical Pharmacology;2019-09-23

5. Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy;Antimicrobial Agents and Chemotherapy;2018-11